High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader
{{output}}
Background: Recent advances in targeted therapies have introduced molecular glue degraders (MGDs) that leverage the cereblon (CRBN) E3 ubiquitin ligase to degrade the translation termination factor GSPT1. Understanding the cellul... ...
